Sofia Necander

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial

Claus Bachert, Joseph K. Han, Martin Y. Desrosiers et al. · Journal of Allergy and Clinical Immunology · 2021 · 307 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +12

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

Michael E. Wechsler, Parameswaran Nair, Benjamin Terrier et al. · New England Journal of Medicine · 2024 · 186 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +15

A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma

Ioannis Psallidas, Vibeke Backer, Piotr Kuna et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 27 citations

Life Sciences, Immunology, Pharmacology +14

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

Dave Singh, Jutta Beier, Carol Astbury et al. · European Respiratory Journal · 2021 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease

Muhammad Waqas Sadiq, Sara Asimus, Maria G. Belvisi et al. · British Journal of Clinical Pharmacology · 2021 · 13 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16